New nerve block could slash opioid use after heart surgery
NCT ID NCT07412522
First seen Feb 17, 2026 · Last updated Jun 22, 2026 · Updated 17 times
Summary
This study tests whether a specific nerve block, called the serratus posterior superior intercostal plane block, can reduce pain and opioid use after minimally invasive heart bypass surgery. Sixty adults undergoing this surgery will be randomly assigned to receive either the nerve block with bupivacaine or standard anesthesia alone. The main goal is to see if the block improves overall recovery quality and reduces the need for painkillers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kosuyolu High Specialization Training and Research Hospital
RECRUITINGIstanbul, 34870, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine
What this could lead to
If effective, this nerve block could become a standard way to manage pain after heart surgery, reducing reliance on opioids and speeding recovery.
What could go wrong
This is a small, early-stage study with only 60 participants. The block may not provide significant pain relief, and there are risks like bleeding or infection at the injection site.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.